The impact of post-market regulatory safety advisories on patients, prescribers, and the healthcare system-Reference-Cited by-同舟云学术

The impact of post-market regulatory safety advisories on patients, prescribers, and the healthcare system

Published:2019-12-19 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Puil Lorri¹,Lexchin Joel²,Bero Lisa³,Mangin Dee⁴,Hallgreen Christine E⁵,Wong Gavin WK⁶,Mintzes Barbara³

Affiliation:

1. University of British Columbia; Department of Anesthesiology, Pharmacology and Therapeutics, Faculty of Medicine; 2176 Health Sciences Mall Vancouver BC Canada V6T 1Z3

2. York University; School of Health Policy and Management; 121 Walmer Rd Toronto ON Canada M5R 2X8

3. The University of Sydney; Charles Perkins Centre and School of Pharmacy, Faculty of Medicine and Health; D17, 6th floor, Charles Perkins Centre, , The University of Sydney | NSW | 2006 Camperdown, Sydney NSW Australia 2006

4. McMaster University; Family Medicine; Hamilton Canada

5. University of Copenhagen; Copenhagen Centre for Regulatory Science (CORS), Department of Pharmacy, Faculty of Health and Medical Sciences; Universitetsparken 2 Copenhagen Denmark 2100

6. University of British Columbia; Centre for Clinical Epidemiology and Evaluation; 828 West 10th Avenue Vancouver British Columbia Canada V5Z 1M9

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013510/epdf/full

Reference92 articles.

1. Australian Government Department of Health Therapeutics Good Administration ACSS NAS work-sharing pilot, 2018 www.tga.gov.au/acss-nas-work-sharing-initiative#pilot

2. Agarwal A Guyatt G Busse J Methods commentary: risk of bias in cross-sectional surveys of attitudes and practices, 2011 www.evidencepartners.com/resources/methodological-resources/risk-of-bias-cross-sectional-surveys-of-attitudes-and-practices/

3. Adverse-drug-reaction-related hospitalizations in developed and developing countries: a review of prevalence and contributing factors;Angamo;Drug Safety,2016

4. Post-marketing drug withdrawals: pharmacovigilance success, regulatory problems;Aronson;Therapie,2017

5. GRADE guidelines: 3. Rating the quality of evidence;Balshem;Journal of Clinical Epidemiology,2011

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Information Sources for Drug Safety and Communicating Risks in Practice;Principles and Practice of Pharmacovigilance and Drug Safety;2024

2. The Effects of Contextual Factors, Self-Efficacy and Motivation on Learners’ Adaptability to Blended Learning in College English: A Structural Equation Modeling Approach;Frontiers in Psychology;2022-04-06